Abbott
India considers price cap on medical devices
Indian regulators may impose price control measures on such medical devices as stents, catheters and implants in response to allegations of price gouging and bribery, according to a report in the Business Standard.
India’s health ministry and department of pharamaceuticals are considering a maximum retail price cap under the National Pharmaceutical Pricing Authority, which monitors the price of 348 medicines deemed essential, the Indian newspaper reported.
Indian media accuse Medtronic, Abbott, J&J of price-hikes, bribery
Some of medtech’s biggest players are getting a beating in the Indian media, where reports this week accused them of turning a blind eye to unethical behavior from their distributors in the country.
TCT 2014 Roundup
Abbott, Medtronic named among world’s greenest companies | MassDevice.com On Call
MASSDEVICE ON CALL — A couple of medtech’s biggest players were named among the Dow Jones Sustainability World Index’s most environmentally responsible companies.
Abbott (NYSE:ABT) led the sector for the greenest practices, ranked according to "financially material economic, environmental, and social factors."